Denmark has purchased 2.4 million doses of the AstraZeneca vaccine. Now, for 149 thousand people who received the first dose of the drug, a new one will be offered later.
The Danish authorities have decided to abandon the vaccination of COVID-a drug of the British-Swedish company AstraZeneca. It was also decided not to use the vaccine of the American company Johnson & Johnson (J&J). This was stated by the head of the department Seren Brustrom at a press conference on Wednesday, April 14.
“The AstraZeneca drug will be excluded from the vaccination program,” he said, adding that the agency believes there is a link between cases of blood clots, bleeding, and low platelet counts and the COVID — 19 vaccines from AstraZeneca.
As explained by the representative of the department Tanya Eriksen, Denmark became the first country in the world to refuse the drug. At the same time, she stressed that her agency agrees with the European Medicines Agency (EMA) and is confident in the effectiveness of the vaccine. Denmark has pre-purchased 2.4 million doses of the vaccine. Now, for 149 thousand people who received the first dose of the drug, a new one will be offered later.
At the same time, the Danish authorities refuse the J&J vaccine until further notice. The agency intends to monitor the information of the EMA and the US Drug Agency, as well as to study the effectiveness and side effects of all COVID-19 vaccines.
At the end of March, it was announced that Denmark had extended the ban on the use of the AstraZeneca vaccine for three weeks. At the same time, the country was one of the first to announce the stop of vaccination. The cause was the death of a 60-year-old woman who was found to have blood clots after vaccination.